The high precision measurement of the hyperfine splitting of the muonic-hydrogen atom ground state with pulsed and intense muon beam requires careful technological choices both in the construction of a gas target and of the detectors. In June 2014, the pressurized gas target of the FAMU experiment was exposed to the low energy pulsed muon beam at the RIKEN RAL muon facility. The objectives of the test were the characterization of the target, the hodoscope and the X-ray detectors.The apparatus consisted of a beam hodoscope and X-rays detectors made with high purity Germanium and Lanthanum Bromide crystals. In this paper the experimental setup is described and the results of the detector characterization are presented. * Andrea.Vacchi@ts.infn.it
The differential cross sections for low-energy muonic hydrogen atom scattering from hydrogenic molecules are directly expressed by the corresponding amplitudes for muonic atom scattering from hydrogen-isotope nuclei. The energy and angular dependence of these three-body amplitudes is thus taken naturally into account in scattering from molecules, without involving any pseudopotentials. Effects of the internal motion of nuclei inside the target molecules are included for every initial rotational-vibrational state. These effects are very significant as the considered three-body amplitudes often vary strongly within the energy interval 0.1 eV. The differential cross sections, calculated using the presented method, have been successfully used for planning and interpreting many experiments in low-energy muon physics. Studies of µ − nuclear capture in pµ and the measurement of the Lamb shift in pµ atoms created in H 2 gaseous targets are recent examples.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.